The PROM1 Gene Cone-Rod Dystrophy Type 12 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the PROM1 gene, which are implicated in the development of Cone-Rod Dystrophy Type 12 (CRD12). This condition is a form of inherited eye disorder that primarily affects the cone and rod cells of the retina, leading to progressive vision loss. The test is crucial for individuals with a family history of CRD12 or those exhibiting symptoms of the disorder, as it provides a definitive diagnosis by analyzing the genetic makeup for specific anomalies in the PROM1 gene.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test involves collecting a DNA sample, usually through a blood draw or cheek swab. The sample is then subjected to comprehensive genetic analysis to detect any mutations associated with CRD12. This information is vital for understanding the risk of developing the condition, potential progression, and guiding decisions regarding management and treatment options.
The cost of the PROM1 Gene Cone-Rod Dystrophy Type 12 Genetic Test at DNA Labs UAE is set at 4400 AED. While the price may seem significant, the value of the information it provides cannot be overstated for affected individuals and their families. It offers a path towards personalized care strategies and, in some cases, might inform decisions about family planning.
The RPGRIP1 Gene Cone-Rod Dystrophy Type 13 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the RPGRIP1 gene that are associated with Cone-Rod Dystrophy Type 13 (CORD13). Cone-Rod Dystrophy is a group of inherited eye disorders that affect the photoreceptor cells responsible for vision, leading to a progressive loss of visual acuity, color vision, and peripheral vision. The RPGRIP1 gene plays a crucial role in the function and survival of these cells, and mutations in this gene can disrupt normal vision and lead to CORD13.
This genetic test is critical for individuals with a family history of Cone-Rod Dystrophy or those experiencing symptoms related to vision impairment, as it provides a definitive diagnosis by detecting the presence of specific genetic mutations. Early diagnosis through genetic testing can help in managing the condition, understanding the risk of passing it on to future generations, and accessing potential treatment options.
The test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of results. The cost of the RPGRIP1 Gene Cone-Rod Dystrophy Type 13 Genetic Test is set at 4400 AED, reflecting the comprehensive analysis and the specialized technology employed in identifying the genetic mutations associated with this condition.
The GUCA1A gene is linked to Cone-Rod Dystrophy Type 14, a rare genetic disorder that affects the retina's ability to respond to light, leading to progressive vision loss. This condition is inherited in an autosomal dominant manner, meaning a mutation in just one copy of the gene can cause the disorder. The GUCA1A Gene Cone-Rod Dystrophy Type 14 Genetic Test is a specialized diagnostic tool designed to identify mutations in the GUCA1A gene that are responsible for the condition. This test is crucial for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding potential treatment and management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA, extracted from a blood sample or cheek swab, to look for specific genetic changes in the GUCA1A gene. The process is comprehensive, ensuring high accuracy in detecting mutations associated with Cone-Rod Dystrophy Type 14.
The cost of the GUCA1A Gene Cone-Rod Dystrophy Type 14 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full process of collecting the sample, conducting the genetic analysis, and providing a detailed report of the findings. The test is a valuable resource for individuals with a family history of the disorder or those experiencing symptoms related to vision loss, offering a clear path to understanding their genetic health and making informed decisions about their future and that of their family.
The CDHR1 gene cone-rod dystrophy type 15 genetic test is a specialized diagnostic procedure designed to detect mutations in the CDHR1 gene, which are associated with cone-rod dystrophy type 15 (CORD15). Cone-rod dystrophy is a group of inherited eye disorders that affect the light-sensitive cells of the retina, leading to progressive vision loss. The CDHR1 gene plays a crucial role in the function and structure of these cells. Mutations in this gene can disrupt normal vision and lead to the early onset of symptoms such as decreased visual acuity, loss of color vision, and night blindness.
This test is particularly important for individuals with a family history of cone-rod dystrophy or those experiencing symptoms suggestive of the disorder. Early and accurate diagnosis through genetic testing can help in managing the condition, understanding its progression, and exploring potential treatment options.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the CDHR1 gene cone-rod dystrophy type 15 genetic test is 4400 AED. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the CDHR1 gene. The results of this test can provide valuable information for affected individuals and their families regarding the diagnosis, prognosis, and potential genetic counseling needs.
The "CD3G Gene Cone-Rod Dystrophy Type 17 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the CD3G gene, which are implicated in Cone-Rod Dystrophy Type 17, a rare genetic disorder. This condition affects the retina, leading to the progressive loss of vision starting with color vision deficits, decreased visual acuity, and loss of peripheral vision, eventually progressing to blindness. The test is crucial for early diagnosis, which can aid in management and understanding the prognosis of the disease.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test provides a comprehensive analysis of the CD3G gene to detect any abnormalities that could indicate the presence of Cone-Rod Dystrophy Type 17. The test cost is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the gene. This genetic test is a vital tool for individuals with a family history of the condition or those experiencing symptoms, offering them a clear diagnosis and the possibility of genetic counseling based on their results.
The CRX Gene Cone-Rod Dystrophy Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the CRX gene, which are linked to Cone-Rod Dystrophy Type 2, a rare genetic disorder. This condition affects the retina and leads to the progressive loss of vision, starting with color vision and night vision difficulties, eventually progressing to a loss of peripheral and central vision. Early detection through this genetic test can be crucial for managing the condition and exploring potential treatment options. The test is priced at 4400 AED and involves a comprehensive analysis of the CRX gene to pinpoint any genetic abnormalities. By opting for this test at DNA Labs UAE, individuals can gain valuable insights into their genetic makeup, enabling them to take proactive steps towards managing their ocular health.
The POC1B gene cone-rod dystrophy type 20 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the POC1B gene that are associated with cone-rod dystrophy type 20. Cone-rod dystrophy is a group of inherited eye disorders that affect the retina's photoreceptor cells, leading to a progressive loss of vision. The POC1B gene plays a crucial role in the structure and function of these cells, and mutations can result in the early onset of vision problems, including loss of visual acuity, color vision defects, and sensitivity to light.
The test is conducted through a blood sample or cheek swab, which is then analyzed for specific genetic variations indicative of the condition. This test is particularly important for individuals with a family history of cone-rod dystrophy or those experiencing symptoms, as early detection can aid in managing the condition and planning for future healthcare needs.
The cost of the POC1B gene cone-rod dystrophy type 20 genetic test at DNA Labs UAE is 4400 AED. This investment allows individuals to gain valuable insights into their genetic makeup, providing an opportunity for early intervention and support for those affected by this form of dystrophy.
The ABCA4 gene cone-rod dystrophy type 3 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the ABCA4 gene that are associated with cone-rod dystrophy type 3, a rare genetic disorder. This condition primarily affects the retina, leading to the progressive loss of vision due to the degeneration of cone and rod photoreceptor cells. Symptoms often include decreased visual acuity, loss of color vision, and sensitivity to light, which can significantly impact the quality of life.
Priced at 4400 AED, the test is conducted through a comprehensive analysis of the patient's DNA, aiming to pinpoint specific genetic alterations within the ABCA4 gene. By identifying these mutations, healthcare providers can offer accurate diagnoses, allowing for better-informed decisions regarding treatment and management of the condition. Additionally, this test can be crucial for family planning purposes, offering at-risk couples insights into their likelihood of passing the condition onto their offspring.
Performed at the state-of-the-art facilities of DNA Labs UAE, the test ensures confidentiality, reliability, and accuracy, employing cutting-edge genetic sequencing technologies. The results from this test not only aid in the diagnosis but also contribute to ongoing research and understanding of cone-rod dystrophy type 3, potentially paving the way for future therapeutic advancements.
The PDE6C Gene Cone-Rod Dystrophy Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at detecting mutations in the PDE6C gene, which are associated with Cone-Rod Dystrophy Type 4 (CORD4). Cone-Rod Dystrophy is a group of inherited eye disorders that affect the light-sensitive cells of the retina, leading to progressive vision loss. The PDE6C gene plays a crucial role in the normal functioning of these cells, and mutations in this gene can disrupt vision by affecting the photoreceptor cells responsible for color vision and visual acuity.
This genetic test is essential for individuals with a family history of Cone-Rod Dystrophy or those experiencing symptoms of the disorder, such as decreased visual acuity, loss of color vision, and difficulty seeing in low light conditions. Early detection through genetic testing can aid in the understanding of the condition, guide management and treatment options, and provide valuable information for family planning.
At DNA Labs UAE, the test is conducted with state-of-the-art technology to ensure accurate and reliable results. The cost of the PDE6C Gene Cone-Rod Dystrophy Type 4 Genetic Test is 3200 AED, reflecting the specialized nature of the test and the advanced techniques employed in the analysis. Individuals undergoing this test can expect comprehensive support from the lab's team, including detailed explanations of the testing process and assistance in interpreting the results.
The PITPNM3 gene is associated with Cone-Rod Dystrophy Type 5 (CORD5), a rare genetic disorder that affects the retina and leads to progressive vision loss. The disorder primarily impacts the cone and rod photoreceptor cells in the eye, which are crucial for color vision, central vision, and low-light vision. Mutations in the PITPNM3 gene disrupt the normal function of these cells, leading to the symptoms of CORD5.
To diagnose this condition, genetic testing can be conducted to identify mutations in the PITPNM3 gene. DNA Labs UAE offers a specific genetic test for this purpose, providing a crucial diagnostic tool for individuals exhibiting symptoms of Cone-Rod Dystrophy Type 5 or those with a family history of the disorder. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of genetic mutations associated with the condition.
The cost of the PITPNM3 gene Cone-Rod Dystrophy Type 5 genetic test at DNA Labs UAE is 4400 AED. This investment can provide invaluable information for affected individuals and their families, enabling them to understand their condition better, consider their options for genetic counseling, and plan for any necessary adjustments to their lifestyle or healthcare management.
